Bench to Bedside Targeting of FLT3 in Acute Leukemia
Journal:
Current Drug Targets
Volume:
11
Page:
781-789
Author(s):
Keith W. Pratz and Mark J. Levis
Vascular Endothelial Growth Factor Receptor as Target for Advanced Non-Small Cell Lung Cancer Therapy
Journal:
Current Drug Targets
Volume:
11
Page:
865-874
Author(s):
Antonio Rossi, Paolo Maione, Paola Claudia Sacco, Rita Ambrosio, Marzia Falanga and Cesare Gridelli
RAGE: A Multi-Ligand Receptor Unveiling Novel Insights in Health and Disease
Journal:
Current Medicinal Chemistry
Volume:
17
Page:
2232-2252
Author(s):
P. Alexiou, M. Chatzopoulou, K. Pegklidou and V.J. Demopoulos
Clinical Pharmacogenetics in Oncology: the Paradigm of Molecular Targeted Therapies
Journal:
Current Pharmaceutical Design
Volume:
16
Page:
2184-2193
Author(s):
Giannis Mountzios, Despina Sanoudou and Konstantinos N. Syrigos
Immunotherapy of Malignant Gliomas Using Autologous and Allogeneic Tissue Cells
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
10
Page:
462-470
Author(s):
F. M. Hofman, A. Stathopoulos, C. A. Kruse, T. C. Chen and V. E.J.C. Schijns
Obesity Modulation - The Role in Carcinogenesis
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
10
Page:
481-490
Author(s):
Ioannis Legakis and Kostantinos Syrigos
The Role of Nuclear Factor-κB in Inflammatory Lung Disease
Journal:
Inflammation & Allergy - Drug Targets (Discontinued)
Volume:
9
Page:
197-205
Author(s):
Abbas Ali Imanifooladi, Samaneh Yazdani and Mohammad Reza Nourani
Prediction of Disease-Related Genes Based on Hybrid Features
Journal:
Current Proteomics
Volume:
7
Page:
82-89
Author(s):
Mingxiao Li, Zhibin Li, Zhenran Jiang and Dandan Li
Recognition of Nucleic Acids by Toll-Like Receptors and Development of Immunomodulatory Drugs
Journal:
Current Medicinal Chemistry
Volume:
17
Page:
1899-1914
Author(s):
A. Kuznik, G. Panter and R. Jerala
Targeting the p53-Family in Cancer and Chemosensitivity: Triple Threat
Journal:
Current Drug Targets
Volume:
11
Page:
667-681
Author(s):
J. Chung and M.S. Irwin